119 related articles for article (PubMed ID: 36621663)
1. Generation of the novel anti-FXYD5 monoclonal antibody and its application to the diagnosis of pancreatic and lung cancer.
Hotta T; Nariai Y; Kajitani N; Kadota K; Maruyama R; Tajima Y; Isobe T; Kamino H; Urano T
Biochimie; 2023 May; 208():160-169. PubMed ID: 36621663
[TBL] [Abstract][Full Text] [Related]
2. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
O'Sullivan D; Dowling P; Joyce H; McAuley E; McCann A; Henry M; McGovern B; Barham P; Kelleher FC; Murphy J; Kennedy S; Swan N; Moriarty M; Clynes M; Larkin A
Br J Cancer; 2017 Oct; 117(9):1326-1335. PubMed ID: 28881357
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of (89)Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer.
Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
PLoS One; 2013; 8(4):e61230. PubMed ID: 23577210
[TBL] [Abstract][Full Text] [Related]
4. 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.
O'Sullivan D; Henry M; Joyce H; Walsh N; Mc Auley E; Dowling P; Swan N; Moriarty M; Barnham P; Clynes M; Larkin A
Tumour Biol; 2014 Jul; 35(7):6983-97. PubMed ID: 24744142
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
6. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
Xu M; Yuan Y; Xia Y; Achilefu S
Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
[TBL] [Abstract][Full Text] [Related]
8. ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer.
Chen W; Li M; Younis MH; Barnhart TE; Jiang D; Sun T; Lang JM; Engle JW; Zhou M; Cai W
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):861-870. PubMed ID: 34519889
[TBL] [Abstract][Full Text] [Related]
9. Establishment of H
Yamada S; Itai S; Nakamura T; Chang YW; Harada H; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):287-290. PubMed ID: 29172998
[TBL] [Abstract][Full Text] [Related]
10. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
Arnoletti JP; Buchsbaum DJ; Huang ZQ; Hawkins AE; Khazaeli MB; Kraus MH; Vickers SM
J Gastrointest Surg; 2004 Dec; 8(8):960-9; discussion 969-70. PubMed ID: 15585383
[TBL] [Abstract][Full Text] [Related]
12. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
13. [Development of a Pancreatic Cancer Specific Binding Peptide Using Phage Display].
Lee DW; Park JM; Yang SM; Kwak MH; Roh YJ; Lee IS; Choi MG
Korean J Gastroenterol; 2019 Jul; 74(1):30-41. PubMed ID: 31344770
[TBL] [Abstract][Full Text] [Related]
14. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.
Arias-Pinilla GA; Dalgleish AG; Mudan S; Bagwan I; Walker AJ; Modjtahedi H
Sci Rep; 2020 Jan; 10(1):537. PubMed ID: 31953437
[TBL] [Abstract][Full Text] [Related]
15. The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunits.
Tokhtaeva E; Sun H; Deiss-Yehiely N; Wen Y; Soni PN; Gabrielli NM; Marcus EA; Ridge KM; Sachs G; Vazquez-Levin M; Sznajder JI; Vagin O; Dada LA
J Cell Sci; 2016 Jun; 129(12):2394-406. PubMed ID: 27142834
[TBL] [Abstract][Full Text] [Related]
16. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG
Kaneko MK; Ohishi T; Kawada M; Kato Y
Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928
[TBL] [Abstract][Full Text] [Related]
17. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.
Balouchi-Anaraki S; Ahmadvand S; Safaei A; Ghaderi A
Iran Biomed J; 2021 Sep; 25(5):310-22. PubMed ID: 34425650
[TBL] [Abstract][Full Text] [Related]
18. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.
England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W
Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683
[TBL] [Abstract][Full Text] [Related]
19. Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.
Kapelski S; Boes A; Spiegel H; de Almeida M; Klockenbring T; Reimann A; Fischer R; Barth S; Fendel R
Malar J; 2015 Feb; 14():50. PubMed ID: 25651860
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional interactions between FXYD5 and the Na+-K+-ATPase.
Lubarski I; Karlish SJ; Garty H
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1818-26. PubMed ID: 17881459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]